ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Roche Markets CMV Test in Europe

April 29, 2011

Gio Gori And The “Tolerable” Smoking Flap; Controversy When He Needs It Least

August 18, 1978

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008